(c) 2024 PillSync.com

DILTIAZEM HYDROCHLORIDE 180 mg

INDICATIONS AND USAGE Diltiazem hydrochloride extended-release capsules, USP is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules, USP is indicated for the management of chronic stable angina and angina due to coronary artery spasm.

Par Pharmaceutical, Inc.


3 years ago CAPSULE GREEN Par C830 DILTIAZEM HYDROCHLORIDE 180 mg

CAPSULE GREEN Par C830

HOW SUPPLIED

DILTIAZEM HYDROCHLORIDE Extended-Release capsules, USP Strength Quantity NDC Number Description 120 mg 30 counts 10370-829-11 Hard gelatin capsules light gray opaque cap and light gray opaque body imprinted with “par” on the cap and “C829” on the body in black ink. Each capsule contains white to off white coated pellets. 90 counts 10370-829-09 500 counts 10370-829-05 180 mg 30 counts 10370-830-11 Hard gelatin capsules with dark green opaque cap and blue opaque body imprinted with “par” on the cap and “C830” on the body in black ink. Each capsule contains white to off white coated pellets. 90 counts 10370-830-09 500 counts 10370-830-05 240 mg 30 counts 10370-831-11 Hard gelatin capsules with dark green opaque cap and dark green opaque body imprinted with “par” on the cap and “C831” on the body in black ink. Each capsule contains white to off white coated pellets. 90 counts 10370-831-09 500 counts 10370-831-05 300 mg 30 counts 10370-832-11 Hard gelatin capsules with dark green opaque cap and light gray opaque body imprinted with “par” on the cap and “C832” on the body in black ink. Each capsule contains white to off white coated pellets 90 counts 10370-832-09 500 counts 10370-832-05 Store at 20º to 25ºC (68º to 77ºF). [See USP Controlled Room Temperature] Avoid excessive humidity. Dist. by: Par Pharmaceutical Cranbury, NJ 08512 U.S.A. Mfg. by: Par Formulations Private Limited, M82 and M83, Industrial Area, SEZ, Phase II, Pithampur, Dhar, MP - 454775, District- DHAR Made in India Mfg. Lic. No.: 25/82/2020 OS829-01-74-01 Issued: 12/2021


More pills like CAPSULE Par C830

Related Pills

diltiazem hydrochloride 180 mg

par pharmaceutical, inc.

DILTIAZEM HYDROCHLORIDE 120 mg

Par Pharmaceutical, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site